NeurOptics
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9223 Research Dr, Irvine, California, 92...Phone Number
(949) 250-9792Website
www.neuroptics.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About NeurOptics
NeurOptics specializes in developing and marketing innovative pupillometry technology for critical care medicine, neurology, neurosurgery, emergency medicine, and research. Their product line includes various models of pupillometers, such as the NPi-300 and VIP series, designed to enhance pupillary assessment and improve patient outcomes. The company serves a global market, with representation in over 50 countries and adoption in more than 1,000 hospitals across the U.S. NeurOptics aims to provide clinicians with accurate, reliable, and objective data to support clinical decision-making.Explore more
NeurOptics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeurOptics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at NeurOptics
Check out if NeurOptics is spiking on competitors!
Funding: Get notified immidiatlly once NeurOptics has new funding data
Check if NeurOptics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on NeurOptics recently announced quarterly report
NeurOptics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when NeurOptics launches new products
Click to see if NeurOptics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at NeurOptics
Find more new buyers
Compare Similar Companies to NeurOptics
Compare insights from companies similar to NeurOptics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
<$5M
-
AG
Adam GriggsVice President of Pulmonary Disease Specialists, PA and Co-director of Central Florida Sleep Centers
Company Profile Activity
Activity Insights
NeurOptics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NeurOptics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NeurOptics.
NeurOptics financials insights
Gather financial insights about NeurOptics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$1.2M
2016
Debt
$500K
2020
Debt
$350K
NeurOptics Tech Stack
A closer look at the technologies used by NeurOptics
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Project
Award, Spending/Investment, Product Development, Analytics & Insights, Forecasting, Safety, Healthcare Technology
Open Position
Product Launch
Engineering, Product Launch, Automation
Project
Enterprise Software, Financial Systems, Software
NeurOptics News & Media
New Clinical Study Shows NeurOptics’ Neurological Pupil Index™, an Important Value for Assessing Brain Injury, is Unaffected by Clinical Intoxication
IRVINE, Calif.--(BUSINESS WIRE)--A newly published clinical study showed that NeurOptics’ Automated Pupillometry and the NPi® remain unaffected by clinical intoxication.New Emergency Department Study Shows NeurOptics’ Neurological Pupil Index™ is Unaffected by Clinical Intoxication
Results show Automated Pupillometer and NPi® can be used for patient evaluation and triage without risk of confounding by key intoxicants of abuse IRVINE, CALIF., USA, January 10, 2023 /EINPresswire.com/ -- A newly published clinical study shows that …NeurOptics’ Neurological Pupil index™ and Automated Pupillometry Included in Latest European Guidelines for Post-Resuscitation Care
IRVINE, Calif.--(BUSINESS WIRE)--The Neurological Pupil index™ (NPi®) and automated NPi pupillometry globally emerging as important for use in patients following cardiac arrest.New Peer-Reviewed Study Leverages NeurOptics’ Automated Pupillometry to Measure Pupil Reactivity Differences, an Earlier Indicator of Neurological Injury
IRVINE, Calif.--(BUSINESS WIRE)--A new peer-reviewed study shows that even one occurrence of an abnormal NPi® differential can be an early indicator of neurological injury.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeurOptics
Sign Up For FreeTo access detailed company insights
NeurOptics specializes in developing and marketing innovative pupillometry technology for critical care medicine, neurology, neurosurgery, emergency medicine, and research. Their product line includes various models of pupillometers, such as the NPi-300 and VIP series, designed to enhance pupillary assessment and improve patient outcomes. The compa... Read More
